NCT03926845View on ClinicalTrials.gov

Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation

NACompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

January 31, 2021

Conditions

Facial Hyperpigmentation

Interventions

OTHER

Isobutylamido-thiazolyl-resorcinol Cream 0.2%

Each bottle contains Isobutylamido-thiazolyl-resorcinol cream 0.2% to be applied on the entire face twice daily for 12 weeks.

OTHER

Vehicle

Each bottle contains vehicle cream to be applied on the entire face twice daily for 12 weeks.

Trial Locations (1)

10400

Institute of Dermatology, Ratchathewi

All Listed Sponsors

collaborator

Beiersdorf (Thailand) Co., Ltd.

UNKNOWN

lead

Institute of Dermatology, Thailand

OTHER_GOV

NCT03926845 - Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation | Biotech Hunter | Biotech Hunter